scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-5347(05)67026-7 |
P698 | PubMed publication ID | 11025702 |
P2093 | author name string | Potts JM | |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1550-1553 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Journal of Urology | Q15709979 |
P1476 | title | Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen | |
P478 | volume | 164 |
Q35738225 | A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammation |
Q28253200 | Acute and chronic prostatitis |
Q40205416 | Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen |
Q41934883 | Changes in the Normal Cellular Architecture in the Prostatic Tissue with the Increasing age. |
Q35159825 | Chronic pelvic pain syndrome: a non-prostatocentric perspective |
Q36456149 | Dealing with non-cancerous findings on prostate biopsy |
Q34767678 | Diagnosing the prostatitis patient: the dilemma continues |
Q55350987 | Differential expression patterns of housekeeping genes increase diagnostic and prognostic value in lung cancer. |
Q49164947 | Do antibiotics decrease prostate-specific antigen levels and reduce the need for prostate biopsy in type IV prostatitis? A systematic literature review |
Q36575823 | Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL? |
Q36450786 | Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy? |
Q53647769 | Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. |
Q39756197 | Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml. |
Q37682420 | Inflammatory changes in biopsy specimens from patients with suspected prostate cancer |
Q81133184 | Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study |
Q37537786 | Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis |
Q80633099 | PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients |
Q34767705 | Phytotherapy and other alternative forms of care for the patient with prostatitis |
Q34775766 | Prevalence of asymptomatic inflammatory (National Institutes of Health Category IV) prostatitis in young men according to semen analysis |
Q35151989 | Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis |
Q37258897 | Prostate cancer and chronic prostatitis |
Q35683035 | Prostate kallikrein markers in diagnosis, risk stratification and prognosis. |
Q82405984 | Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome |
Q24646945 | Prostatitis and male pelvic pain syndrome: diagnosis and treatment |
Q35982328 | Prostatitis and prostate cancer: implications for prostate cancer screening |
Q36174680 | Prostatitis and serum prostate-specific antigen |
Q49091944 | Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases |
Q83912941 | Seminal interleukin-6 and serum prostate-specific antigen as possible predictive biomarkers in asymptomatic inflammatory prostatitis |
Q34239009 | The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride |
Q53097022 | The Effect of a Pure Anti-inflammatory Therapy on Reducing Prostate-specific Antigen Levels in Patients Diagnosed With a Histologic Prostatitis. |
Q77291647 | The New Age of Prostatitis |
Q81707729 | The case for prostate-specific antigen screening starting at age 40 |
Q37089968 | The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mL |
Q28258235 | Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome |
Q80531033 | [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin] |
Search more.